血液系统恶性肿瘤的双靶向 CAR-T 细胞免疫治疗:2023 ASH 年会最新进展 Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting. PubMed 2024/02/27 发表Exp Hematol OncolQ1 · IF 17.5(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T技术:NK 细胞技术:NKT 细胞
鼻窦黏膜黑色素瘤中 TIL(肿瘤浸润淋巴细胞)的特征及患者预后 Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients. PubMed 2022/06/11 发表Curr Probl CancerQ3 · IF 2.4(JCR 2025) 靶点:CD20技术:NK 细胞技术:NKT 细胞黑色素瘤地区:中国